Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
125.4 USD | +0.25% | -1.09% | +15.00% |
Apr. 15 | Zacks Adjusts Price Target on Merck & Company to $132 From $128 | MT |
Apr. 11 | Merck & Co Receives a Shareholder Proposal from The Bahnsen Family Trust | CI |
Financials (USD)
Sales 2024 * | 63.78B | Sales 2025 * | 68.02B | Capitalization | 318B |
---|---|---|---|---|---|
Net income 2024 * | 19.51B | Net income 2025 * | 21.75B | EV / Sales 2024 * | 5.29 x |
Net Debt 2024 * | 19.65B | Net Debt 2025 * | 7.53B | EV / Sales 2025 * | 4.78 x |
P/E ratio 2024 * |
16.1
x | P/E ratio 2025 * |
14.1
x | Employees | 71,000 |
Yield 2024 * |
2.44% | Yield 2025 * |
2.58% | Free-Float | 70.75% |
Latest transcript on Merck & Co., Inc.
1 day | +0.25% | ||
1 week | -1.09% | ||
Current month | -4.99% | ||
1 month | +3.17% | ||
3 months | +6.13% | ||
6 months | +20.35% | ||
Current year | +15.00% |
Managers | Title | Age | Since |
---|---|---|---|
Robert Davis
CEO | Chief Executive Officer | 57 | 14-03-31 |
Director of Finance/CFO | 55 | 89-12-31 | |
Dave Williams
CTO | Chief Tech/Sci/R&D Officer | 55 | 20-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Tom Glocer
BRD | Director/Board Member | 63 | 07-11-26 |
Pamela Craig
BRD | Director/Board Member | 67 | 15-08-31 |
Inge Thulin
BRD | Director/Board Member | 69 | 18-02-28 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
14.34% | 215 M€ | +12.15% | - | |
5.61% | 18 M€ | +2.91% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-17 | 125.4 | +0.25% | 6,122,908 |
24-04-16 | 125.1 | -0.90% | 5,587,332 |
24-04-15 | 126.2 | +0.36% | 6,241,069 |
24-04-12 | 125.7 | -0.33% | 7,369,989 |
24-04-11 | 126.2 | -0.47% | 6,187,364 |
Delayed Quote Nyse, April 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.00% | 318B | |
+28.79% | 676B | |
+24.81% | 554B | |
-7.64% | 349B | |
+5.99% | 291B | |
+2.47% | 210B | |
-0.02% | 204B | |
-9.98% | 194B | |
-11.71% | 144B | |
-8.32% | 142B |
- Stock Market
- Equities
- MRK Stock